HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibasal Ganglia Antibodies and Antistreptolysin O in Noncomorbid ADHD.

AbstractOBJECTIVE:
An association between streptococcal infections, ABGA positivity, and no comorbidity ADHD (nc-ADHD) has been little investigated. The aim of this study was to evaluate the streptococcal infection frequency, defined entitled serum antistreptolysin O (ASO), and frequency of serum ABGA positivity in a sample of patients with nc-ADHD.
METHOD:
In all 40 participants were investigated the ASO titer and ABGA.
RESULTS:
The results showed that ABGA positivity was statistically significantly higher in patients affected by ADHD than in patients of a control group, and pathological values of ASO were statistically more frequent in the ADHD group than the control group.
CONCLUSION:
These data suggest that streptococcal infections and autoimmune reactions against the basal ganglia are more frequent in ADHD patients than patients in a control group.
AuthorsMaddalena Toto, Francesco Margari, Marta Simone, Francesco Craig, Maria Giuseppina Petruzzelli, Silvio Tafuri, Lucia Margari
JournalJournal of attention disorders (J Atten Disord) Vol. 19 Issue 11 Pg. 965-70 (Nov 2015) ISSN: 1557-1246 [Electronic] United States
PMID22956712 (Publication Type: Journal Article)
Copyright© The Author(s) 2012.
Chemical References
  • Antibodies, Bacterial
  • Autoantibodies
  • Biomarkers
  • Immunologic Factors
  • Antistreptolysin
Topics
  • Adolescent
  • Antibodies, Bacterial (analysis)
  • Antistreptolysin (analysis)
  • Attention Deficit Disorder with Hyperactivity (epidemiology, immunology, microbiology)
  • Autoantibodies (blood, immunology)
  • Basal Ganglia (immunology)
  • Biomarkers (analysis, blood)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunologic Factors
  • Male
  • Prevalence
  • Streptococcal Infections (diagnosis, epidemiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: